Abstract
Background Persisting self-blaming emotional biases were previously associated with vulnerability to major depressive disorder (MDD). More specifically self-contempt/disgust biases distinguished remitted MDD, compared with never-depressed control participants. The contribution of action tendencies to MDD vulnerability and their relationship with blame-related emotions to prepare for subsequent behaviour is elusive. Here, we investigated whether maladaptive action tendencies such as “creating a distance from oneself” and “hiding” are associated with MDD vulnerability, as well as with self-disgust/contempt and shame respectively.
Methods 76 participants with medication-free remitted MDD and 44 healthy control (HC) participants without a personal or family history of MDD completed the value-related moral sentiment task, which measured their blame-related emotions during hypothetical social interactions and a novel task to assess their blame-related action tendencies.
Results As predicted, the MDD group exhibited a higher proneness to feeling like hiding and creating a distance from themselves compared with the HC group. Interestingly, apologising for one’s wrongdoing, was associated with all self-blaming emotions including shame, guilt, self-contempt/disgust and self-indignation, but was more common in HC. In contrast, apologising and perceiving to be in control of one’s friend’s wrongdoings were more common in MDD. Although shame was indeed associated with hiding, this was also true of guilt. Self-disgust/contempt was associated with attacking rather than creating a distance from oneself.
Conclusions MDD vulnerability was associated with specific maladaptive action tendencies which were not clearly predicted by the type of emotion, thus unveiling novel cognitive markers and neurocognitive treatment targets.
General Scientific summary This study confirmed the hypothesis that specific maladaptive action tendencies related to self-blame, such as feeling like hiding and feeling like creating a distance from oneself, were distinctive of people with major depressive disorder, even on remission of symptoms. These action tendencies were not clearly predicted by the type of emotion experienced, showing the importance of assessing them directly. This calls for novel psychological and neurocognitive treatments specifically aiming at maladaptive action tendencies which have so far not been directly addressed in standard assessments and treatments.
Competing Interest Statement
RZ is a private psychiatrist service provider at The London Depression Institute, has collaborated with e-health companies EMIS PLC and Alloc Modulo Ltd. He has received honoraria from pharmaceutical companies (Lundbeck, Janssen) for scientific presentations and is a co-investigator for a Livanova-funded study on Vagus Nerve Stimulation. None of the other authors report biomedical financial interests or potential conflicts of interest related to the subject of this paper.
Funding Statement
This study was funded by an MRC Clinician Scientist Fellowship to RZ (G0902304). RZ was partly funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London and by a NARSAD Independent Investigator Grant (24715) from the Brain & Behavior Research Foundation. SQ was partly funded by a Henry Lester Trust Award. This study was funded by the UK Medical Research Council (G0902304).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the South Manchester NHS Research Ethics Committee. All participants have given written informed consent after the procedures of the study have been fully explained.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data is available from the corresponding author upon reasonable request.